On Invalid Date, Perspective Therapeutics (NYSEMKT: CATX) reported Q4 2023 earnings per share (EPS) of -$0.09, up 350% year over year. Total Perspective Therapeutics earnings for the quarter were -$24.68 million. In the same quarter last year, Perspective Therapeutics's earnings per share (EPS) was -$0.02.
As of Q2 2024, Perspective Therapeutics's earnings has grown year over year. Perspective Therapeutics's earnings in the past year totalled -$46.51 million.
What was CATX's revenue last quarter?
On Invalid Date, Perspective Therapeutics (NYSEMKT: CATX) reported Q4 2023 revenue of -$4.90 million up 185.5% year over year. In the same quarter last year, Perspective Therapeutics's revenue was -$1.72 million.
What was CATX's revenue growth in the past year?
As of Q2 2024, Perspective Therapeutics's revenue has grown null year over year. Perspective Therapeutics's revenue in the past year totalled $1.43 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.